A61K 31/497
Containing further heterocyclic rings
Official title: containing further heterocyclic rings
A61K31/497 (Containing further heterocyclic rings) appears on 1,879 US grants and 3,529 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,879
- Published applications
- 3,529
- Assignees
- 1,255
- Inventors
- 8,795
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 3 | 0 |
| 1997 | 5 | 0 |
| 1998 | 5 | 0 |
| 1999 | 6 | 0 |
| 2000 | 9 | 0 |
| 2001 | 10 | 4 |
| 2002 | 10 | 19 |
| 2003 | 10 | 34 |
| 2004 | 10 | 49 |
| 2005 | 16 | 57 |
| 2006 | 29 | 59 |
| 2007 | 23 | 55 |
| 2008 | 27 | 83 |
| 2009 | 20 | 68 |
| 2010 | 31 | 99 |
| 2011 | 32 | 108 |
| 2012 | 43 | 85 |
| 2013 | 91 | 161 |
| 2014 | 118 | 202 |
| 2015 | 136 | 191 |
| 2016 | 144 | 194 |
| 2017 | 137 | 197 |
| 2018 | 142 | 208 |
| 2019 | 135 | 194 |
| 2020 | 124 | 167 |
| 2021 | 122 | 187 |
| 2022 | 86 | 169 |
| 2023 | 102 | 209 |
| 2024 | 82 | 243 |
| 2025 | 101 | 268 |
| 2026 | 70 | 219 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods comprising endothelin a receptor antagonists and androgen therapies29 Sep 2026US 12,746,239 B2The United States Government as represented by the Department of Veterans Affairs
- LOX enzyme inhibiting methods and compositions29 Sep 2026US 12,746,243 B2Anovia Biosciences, Inc.
- Heterocyclic compounds for the control of invertebrate pests22 Sep 2026US 12,740,561 B2BASF SE
- Methods and compositions for treating cancer22 Sep 2026US 12,740,976 B2City of Hope
- Methods of treating ischemic disease by administering an ATR kinase inhibitor22 Sep 2026US 12,740,980 B2East Tennessee State University Research Foundation
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Combination therapy for pulmonary hypertension8 Oct 2026US 2026/0306461 A1Vivus, Inc.
- Inverse agonists of rar related orphan receptors (rors)8 Oct 2026US 2026/0306484 A111949098 CANADA INC. (NUREDCO) c/o Jean I. TCHERVENKOV
- Cis-8-(3,5-Difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives8 Oct 2026US 2026/0308140 A1Gruenenthal GmbH
- Substituted pyridinone compounds and uses thereof1 Oct 2026US 2026/0294879 A1Pfizer Inc.
Most cited
By later US patents
- Penetrating pharmaceutical foam145US 7,700,076 B2Foamix Ltd. · 2010
- Pyrazole compound and medicinal composition containing the same142US 7,429,609 B2Eisai R&D Management Co., Ltd. · 2008
- Pyrazole compositions useful as inhibitors of ERK126US 6,784,195 B2Vertex Pharmaceuticals Incorporated · 2004
- Modulators of ATP-binding cassette transporters124US 7,659,268 B2Vertex Pharmaceuticals Incorporated · 2010
- Modulators of ATP-binding cassette transporters116US 7,741,321 B2Vertex Pharmaceuticals Incorporated · 2010